Probiotics China News Bites – April 2026
(Source: HPA-Global)
Category: New
China’s Blueberry Boom Signals Growing Demand for Health-Focused Foods
China’s blueberry industry is experiencing rapid growth, driven by rising consumer demand and expanding domestic production. Blueberries, once considered a premium imported fruit, are now increasingly produced locally and available […]
China CFSA Collect Public Consultation Open for 4 New Food Ingredients
On April 22, 2026, China National Center for Food Safety Risk Assessment (CFSA) issued 4 new food materials. Comments are welcomed before May 22, 2026. Details are as follows: 1. Glucosyl hesperidin […]
Hong Kong Beauty and Health Products Finding Mainland Success
According to industry insiders, the focus of China’s beauty industry is undergoing something of a shift as it stops simply prioritising expansion and puts greater emphasis on value and quality […]
H&H Delivers Strong Q1 Revenue Growth on China-Driven Nutrition Demand and Deleveraging
Health and Happiness (H&H) International Holdings reported a 34.4% year-on-year rise in first-quarter 2026 revenue to RMB4.26 billion, with high-margin nutritional supplements contributing nearly 60% of sales. Growth was broad-based […]
Traditional Plant Extract Shows Potential for Bone and Mood Health—But Human Evidence Still Needed
A recent study has drawn attention to Drynaria fortunei (骨碎补), a traditional Chinese medicinal plant long used for bone health. The Chinese name actually translates as “broken bone mender”, which […]
China’s $24 Billion Pet Food Market Heats Up
China’s pet food market has grown into a $24 billion industry, expanding rapidly as pet ownership rises and consumers shift toward higher-quality nutrition. A notable trend is the increasing preference […]
NAD+ Precusor Nicotinamide Riboside Chloride Sets Gold Standard with USP Monograph
In this interview, we speak with Niagen Bioscience’s Sr. VP Global Scientific & Regulatory Affairs Andrew Shao about the significance of achieving the first-ever USP monograph for nicotinamide riboside chloride […]
Scitop’s Smart Probiotic Factory Completed
On April 11, the smart probiotic factory of Inner Mongolia Scitop Biotechnology Co., Ltd., a wholly owned subsidiary of Scitop, was officially completed in Hohhot, with a total investment of […]
Yongan Pharmaceutical Reports 2025 Revenue of RMB 783 Million
On April 16, Yongan Pharmaceutical disclosed its annual report, reporting operating revenue of RMB 783 million (≈ US$114.8 million), down 6.63% year on year, and net profit of RMB 22.49 […]